trending Market Intelligence /marketintelligence/en/news-insights/trending/6j6le0e1on-fnp79wjrlla2 content esgSubNav
In This List

Cerus adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cerus adds board member

Cerus Corp. appointed Eric Bjerkholt as a director.

Bjerkholt is the CFO of Aimmune Therapeutics Inc., which develops treatments for people with food allergies. He is also a board member at Corium International Inc.

Concord, Calif.-based Cerus develops biomedical products, with a focus on blood transfusion safety.